Alan Seth Krasner

This profile gathers the share dealings of Alan Seth Krasner across 2 companies, led by Albireo Pharma, Inc. and Crinetics Pharmaceuticals, Inc. Over a trading history stretching from 9 November 2009 to 17 October 2023, the count stands at 20 filings.

The open-market side counts 1 purchase for €29k alongside 5 sales for €335k. Sales outweigh purchases by €306k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 6 share grants and 8 option exercises. In 2023 alone, the filings show no purchases and 1 sale.

Most recently, on 19 October 2023, the filings show an open-market sale worth €199k in Crinetics Pharmaceuticals, Inc. The most recent open-market purchase was published on 20 July 2018, 3,034 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.